Review Article
Prognostic Models for Predicting Overall Survival in Patients with Primary Gastric Cancer: A Systematic Review
Table 1
Characteristics of 101 model developments.
| | | Model developments (n = 101) |
| | Study characteristics | | Publication year | | | Before 2000 | 3 | | 2001–2010 | 7 | | 2011–2018 | 91 | | Study location | | | East Asia (China/Japan/Korea) | 76 | | Non-Asian | 25 | | Data source | | | Clinical data/retrospective cohort | 91 | | Prospective cohort | 7 | | Randomized controlled trial | 3 | | Patient characteristics | | Male% (4/101 missing) | 67.6 (30.9, 80.3)a | | Age (5/101 missing) | | | Median (min, max) of mean | 60.0 (51.0, 70.0)a | | Tumor TNM stage | | | All | 46 | | I–III | 36 | | IV | 17 | | No information | 2 | | Gastrectomy | | | No restriction | 28 | | Only patients with gastrectomy | 71 | | Only patients without gastrectomy | 2 | | Model development | | Sample size (training set) (14/101 missing) | 360 (29, 15320)a | | Number of events | 193 (14, 9560)a | | Event per variable (18/101 missing) | 25.1 (0.2, 1481.3)a | | Length of follow-up (month) (53/101 missing) | 44.0 (6.7, 111.6)a | | Start of outcome follow-up | | | From diagnosis | 3 | | From surgery | 49 | | From other time pointsb | 15 | | Unclear | 34 | | Candidate selection methods | | | Prespecification | 30 | | Univariable analysis | 63 | | Prespecification + univariable analysis | 5 | | Unclear | 3 | | Statistical model | | | Cox proportional hazard regression | 90 | | Othersc | 11 | | Final predictor selection | | | Full model | 10 | | Stepwise (including forward and backward) | 68 | | Unclear | 23 | | Statistical assumptions ever checked | 9 | | Number of final predictors | 5 (2, 53)a | | Formats of presentations | | | Score | 35 | | Nomogram | 47 | | Equation | 9 | | Others (decision tree and neural network) | 4 | | No | 6 | | Predictive performance | | | Discrimination | | | AUC/c statistic | 67 | | Others | 1 | | No | 33 | | Calibration | | | Calibration plot | 45 | | Hosmer–Lemeshow test | 3 | | No | 55 | | Model validation | | | Internal | 30 | | External | 21 | | No | 54 |
|
|
aMedian (min, max). bInitiation of chemotherapy (n = 10), metastasis (n = 3), and randomization (n = 2). cCART, Cox Lasso, discrimination analysis, Weibull model, neural network, and logistic model. AUC: area under curve.
|